Transport Validation — ASTM D4169 / ISTA

What Is Transport Validation?

Transport validation verifies that packaging integrity is maintained by simulating, in the laboratory, the vibration, drop, compression and climatic conditions the product will encounter with its packaging in the distribution chain. For sterile products, loss of packaging integrity directly means loss of sterility.

Purpose of Transport Validation

The purpose is to prove that the product reaches the user with its sterility and function intact, and to foresee distribution-related damage in advance.

Which Products Is Transport Validation Applied To?

Sterile medical device packaging
Implant and surgical set packaging
Device shipping boxes and palletised shipments
Products requiring a cold chain

In Which Sectors Is Transport Validation Used?

Medical DeviceHealthcarePharmaceuticals

Standards Related to Transport Validation

ASTM D4169
ISTA 1Abasic handling test on packaging test
ISTA 2Apartial simulation test on packaging test
ISTA 3Aparcel transport simulation in packaging test
ISO 11607-1end product sterile barrier packaging test
ASTM D642ambalajlarda basma (kompresyon) testi test
ASTM D999vibration testing on packaging test
ISO 11607end product sterile barrier packaging test

Transport Validation Conditions

Distribution profile: A choice between the distribution cycles (DC) defined in ASTM D4169 or ISTA test protocols
Severity level: Level I, II, III in ASTM D4169; justified according to real distribution conditions
Climatic conditioning: High/low temperature and humidity pre-conditioning, if required

Equipment for Transport Validation

Vibration table (random and sinusoidal)
Drop test machine
Compression test machine
Climate chamber
Packaging-integrity test equipment

Sample Requirements for Transport Validation

Specimens in the final packaging configuration
The real product or an equivalent mass simulator
Including shipping packaging (secondary/tertiary)
The number of specimens must be determined with statistical justification

Duration of Transport Validation

The simulation cycle takes a few days; several weeks together with pre-conditioning and subsequent integrity tests.

Transport Validation Procedure

1The real distribution chain is analysed and the appropriate protocol is chosen.
2Pre-conditioning is applied.
3A compression (stacking) test is performed.
4A vibration test is applied.
5A drop test is performed from the specified heights and orientations.
6The packaging is visually examined after the simulation.
7Seal-strength and integrity tests are repeated.
8Product function is verified.

Transport Validation Acceptance Criteria

The acceptance criterion is that the sterile barrier system retains its integrity after simulation, seal strength does not fall below the specified value, and the product retains its function. Criteria are pre-defined in the validation plan.

Evaluation of Results

Packaging integrity and product function are evaluated separately. Since a micro-hole can be present in packaging that visually appears intact, integrity tests do not substitute for visual inspection.

Transport Validation Report

Distribution-chain analysis and rationale for the chosen protocol
Packaging configuration description
Pre-conditioning conditions
Applied test sequence and parameters
Post-test integrity and seal-strength results
Product-function verification
Photographs

Accreditation

EUROLAB holds internationally recognised accreditation obtained from accreditation bodies party to the IAF and ILAC multilateral recognition arrangements, under ISO/IEC 17025 for laboratory testing, ISO/IEC 17020 for inspection and surveillance, and ISO/IEC 17021-1 and ISO/IEC 17065 for system and product certification. This chain ensures the reports and certificates issued are accepted worldwide.

Whether this test can be offered within accredited scope depends on your product and the standard applied; since accreditation is method-based, the scope is confirmed in writing at the quotation stage.

Scope and authorisations

Related Regulations

MDR (EU) 2017/745
ISO 11607-1

Medikal Cihaz Testleri — What Does This Testing Field Cover?

The section below describes the field that the Transport Validation test belongs to; the conditions and acceptance criteria of this particular test are given in the sections above. The scope specific to your product is confirmed in writing at the quotation stage.

Medical device testing shows that a device is safe for the patient and the user and maintains its intended performance. In this family safety is not only about avoiding harm; a device failing to perform its expected function is also treated as a risk. A monitor missing an alarm or a pump delivering the wrong dose is directly a patient safety event.

At the centre of the field is RISK MANAGEMENT, and this is what sets medical apart from other sectors. The risk management process run under ISO 14971 also determines which tests are required. The test list is not copied from a table of standards; it is derived and justified from the device's intended use, the nature and duration of patient contact, the use environment and foreseeable misuse.

Assessment consists of several separate bodies of work, each with its own set of standards. Biocompatibility runs through the ISO 10993 series, electrical device safety through the IEC 60601 series, sterilisation through ISO 11135/11137/17665, packaging through ISO 11607, software through IEC 62304 and usability through IEC 62366. The quality system (ISO 13485) is the framework that binds these together.

Which tests are required is determined by the device's CLASS and its MODE OF CONTACT WITH THE BODY. A product in brief contact with skin and an implant entering the bloodstream do not go through the same test set; the scope is set by a biological evaluation plan prepared under ISO 10993-1. That plan justifies in writing which endpoints are required and why the others are not.

Packaging and sterilisation are taken as seriously as the device itself in this field. For a sterile device the packaging is not a transport container but the barrier that maintains sterility; if the barrier is breached, the device is no longer sterile. Packaging processes are therefore validated and shelf life is supported by real-time ageing data.

For devices containing software, assessment shifts from testing towards PROCESS assurance. IEC 62304 defines which development and verification steps must be followed according to the safety class of the software; the evidence is the traceability of the development process. Testing software does not make it safe — the process record does.

The clinical side is a separate column of the technical file. Test reports show that the device is technically safe; clinical evaluation establishes that the device delivers the intended clinical benefit and that the benefit-risk balance is acceptable. Neither replaces the other.

Method groups in this field

Biocompatibility
Cytotoxicity, irritation, skin sensitisation, systemic toxicity, haemocompatibility, genotoxicity and local effects after implantation. The required endpoints are set by the ISO 10993-1 plan.
Electrical device safety
IEC 60601-1 basic safety and essential performance; EMC, alarm, usability and environmental requirements through the collateral standards.
Sterilisation validation
Validation of sterilisation processes by ethylene oxide, radiation or moist heat; bioburden and sterility assurance level studies.
Packaging
Integrity of the sterile barrier system, seal strength, distribution simulation and shelf-life studies.
Microbiological tests
Bioburden determination, sterility testing, bacterial endotoxin and, where required, carrier validation studies.
Software and usability
IEC 62304 life cycle evidence and use-error focused evaluation under IEC 62366.

Commonly confused in this field

Cytotoxicity alone is not evidence of biocompatibility; the required set of endpoints is determined and justified according to ISO 10993-1.
An ISO 13485 certificate does not confer CE marking; classification under the MDR, the technical file and the notified body process run separately.
Accelerated ageing does not replace real-time ageing; a shelf life claim is supported by real-time data.
A change of material (supplier, pigment, sterilisation method) may require the biological evaluation to be repeated; it is not a silent change.
An assessment made without the collateral and particular standards for IEC 60601-1 is incomplete; which -1-x and -2-x standards were applied must appear in the report.
In vitro diagnostic devices fall under the IVDR rather than the MDR, and laboratory equipment is often on the IEC 61010-1 side.

Which decisions these results support

MDR/IVDR technical file and notified body assessment
Completing the biological evaluation plan
Sterilisation and packaging validation
Determining shelf life and storage conditions
Determining the scope of reassessment after a design change

Related Tests

Frequently Asked Questions About Transport Validation

Should I choose ASTM D4169 or ISTA?

Both are accepted. ASTM D4169 offers a more flexible framework through choice of distribution cycle and severity level; ISTA protocols are more standardised packages. The choice is expected to be justified according to your real distribution chain.

Can I use a mass simulator instead of the real product?

It can be used, but it must be shown that the simulator represents the real product's mass and stiffness behaviour. If product function also needs to be verified, the real product must be used.